Latest news with #virtualcare
TechCrunch
4 days ago
- Business
- TechCrunch
Omada Health IPO signals healthier market, avoids ‘down-round' trend
The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% jump from the IPO price of $19. The IPO valued the company just above $1 billion (excluding employee options), a figure that's nearly identical to Omada's last private valuation of $1 billion set in its previous VC round. The debut is one of the first among recent IPOs that was not a so-called down-round. Many of the latest public listings, including Hinge, ServiceTitan, and Reddit, priced below their private market highs, though have faired well as public companies. For founder and CEO Sean Duffy, the successful public offering validates his decision to start a company that he believed the market desperately needed. In 2011, he dropped out of Harvard Medical School after realizing that chronic illness patients required more continuous support than the existing healthcare system delivered. Before the offering, he owned 4.1% of the company, according to Omada's offering document. Other significant shareholders included Revelation Partners (10.9%), US Venture Partners (9.9%), Andreessen Horowitz (9.6%), and FMR (9.3%). Duffy told TechCrunch that over his 14-year journey as a founder, he had many harrowing moments. 'I didn't think our series A was going to come together because we were working on this commercial deal that didn't materialize, and that spooked one investor,' he said. Techcrunch event Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA | REGISTER NOW 'As a young business, something tries to kill you every month,' he continued. 'And then as the business grows, it turns into like every quarter or six months, year, two years.' One of the recent challenges for many digital health businesses is navigating the 'collapse' of the market post-COVID boom. Omada navigated the turbulent times by seeking new, rising markets. It recently expanded its offerings to include diet management support for GLP-1 patients.
Reuters
4 days ago
- Business
- Reuters
Digital health company Omada valued at $1.3 billion as shares jump in Nasdaq debut
June 6 (Reuters) - Shares of Omada Health (OMDA.O), opens new tab rose 21% in their Nasdaq debut on Friday, valuing the virtual chronic care provider at $1.28 billion. The robust debut underscores a steady recovery in investor appetite for new listings at a time when U.S. President Donald Trump's shifting tariff policies have rattled markets. A blowout debut of high-risk crypto company and stablecoin issuer Circle Internet (CRCL.N), opens new tab on Thursday also fired up the initial public offering market. Omada shares opened at $23 apiece, compared with its offer price of $19 per share. The San Francisco, California-based company raised $150 million by selling 7.9 million shares in the IPO. Digital health platform Hinge Health (HNGE.N), opens new tab, which debuted in May, has been trading 20.3% higher than its offer price, as of last close.
National Post
27-05-2025
- Business
- National Post
Albertans Want to Use Technology to Support Health Care Access
Article content New study reveals over half of Albertans (57%) believe that hybrid care could improve access to health care amid ER closures and staffing shortages. Article content Article content LETHBRIDGE, Alberta — A new survey conducted by Nanos Group, commissioned by Teladoc Health Canada, reveals that while Albertans continue to face challenges in accessing timely care, particularly in rural areas, there is strong openness to new, innovative solutions that could help relieve pressure on the health care system. Article content How Open are Albertans to Innovation? Article content Over seven in ten Albertans are comfortable or somewhat comfortable with virtual care being used for non-urgent care (39% are comfortable; 35% are somewhat comfortable). Two-thirds of Albertans are comfortable with a hybrid model of care that leverages technology to combine in-person care with virtual clinicians. Article content 'These results show that Albertans are ready to see what their options are when it comes to health care—they are ready for new solutions,' said Joby McKenzie, Managing Director of Teladoc Health Canada. 'It also tells us that many Albertans believe virtual and hybrid care can result in quicker and convenient access to health care. That's why we're committed to working with local leaders and health care partners to expand services that help people get the high quality of care they need faster, while easing pressure on the frontlines.' Article content Released during Alberta Rural Health Week, the survey also highlights the urgency behind this openness. Long wait times, staffing shortages, and delayed care continue to impact patients across the province. Article content Over one in five Albertans wait seven or more hours to be seen in an ER or urgent care centre. The average wait time to access primary care is 10 days. Over one in three Albertans say they've delayed or avoided seeking care due to long wait times. Among people who experienced delayed care, nearly one in five reported worsened health (17%), prolonged pain (10%), or delayed recovery (9%). Article content The survey findings are being released in conjunction with Bridging the Gap: Advancing Rural Health Care through Innovation & Collaboration, an event hosted by the Lethbridge Chamber of Commerce and sponsored by Teladoc Health Canada. The event brings together health care leaders, decision-makers, and providers to explore the role innovation plays in expanding access to care across Alberta. Article content 'As members of the community, we see firsthand how health care access issues affect our families, from overall well-being, productivity, and also, workforce stability,' said Cyndi Crane, CEO of the Lethbridge Chamber of Commerce. 'We're proud to host an event that puts local experts, our unique challenges, and innovative solutions at the centre of the conversation.' Article content Teladoc Health Canada is sharing this new data to help inform ongoing policy and public conversations. Teladoc is committed to collaborating with local and provincial health care leaders to explore how virtual and hybrid care models can help make health care more accessible and timely for Albertans, while supporting care teams and keeping ERs open. Article content Teladoc Health Canada is a Canadian company within the Teladoc Health Group, with a dedicated Canadian team across all functions of the business. Headquartered in Toronto, Teladoc Health Canada has more than 20 years of experience delivering virtual health care to millions of Canadians coast to coast. Through experiences and learnings from providing services in over 175 countries across the world, Teladoc Health Canada has access to world-class research and innovation, enhancing care delivery while maintaining a strong Canadian focus. Article content The Lethbridge Chamber of Commerce is the voice of business, advocating for policies that support a thriving local economy. With a strong network of members, the Chamber champions innovation, growth, and collaboration across all sectors. As a catalyst for positive change, it remains committed to building a prosperous future for Lethbridge and our surrounding region. Article content Article content Article content Article content Article content Article content
Yahoo
25-05-2025
- Business
- Yahoo
Best Online Psychiatrist (2025): Talkiatry Awarded Top Telepsychiatry Service by Better Business Advice
Better Business Advice has named Talkiatry the Best Online Psychiatrist of 2025 NEW YORK CITY, May 25, 2025 (GLOBE NEWSWIRE) -- Better Business Advice has named Talkiatry the Best Online Psychiatrist of 2025, recognizing the company's innovation, accessibility, and impact in the rapidly evolving field of telepsychiatry. Best Online Psychiatrist Talkiatry - a national mental health practice known for delivering in-network, virtual psychiatric care that prioritizes clinical integrity and patient accessibility. Founded by a mental health advocate and a triple-board-certified psychiatrist, Talkiatry was created to address the structural and systemic issues that prevent millions of Americans from receiving timely and affordable mental health treatment. The announcement comes at a time when the demand for mental health services in the United States continues to outpace access. An estimated 60% of adults with a diagnosable mental illness go without treatment each year. Contributing factors include long wait times, geographic disparities, limited provider networks, and a fragmented reimbursement system that deters clinicians from participating in insurance programs. Expanding Access Through Virtual Psychiatry Talkiatry has positioned itself to meet these challenges head-on. With over 500 licensed psychiatrists operating across 47 states and partnerships with more than 100 major insurance providers, the practice has already facilitated almost two million virtual patient visits. Appointments are often available within days, and all services are conducted via HIPAA-compliant, secure video sessions. 'Talkiatry stands out for its commitment to increasing access to psychiatry without compromising on quality or clinical oversight,' said a spokesperson for Better Business Advice. 'Its model represents a forward-thinking approach to healthcare delivery, and more importantly, it responds to what patients and clinicians have been asking for - care that is timely, effective, and equitable.' Talkiatry's process begins with a detailed online intake to determine eligibility and insurance coverage. Once matched, patients are paired with a psychiatrist licensed in their state. Initial appointments typically last 60 minutes and include a full psychiatric evaluation, after which a treatment plan is developed. For patients who require it, medication management is also available. Follow-up appointments are tailored to individual needs and are usually 30 minutes for adults. Clinical Range, Affordability, and Responsible Care The practice treats a wide range of psychiatric conditions, including anxiety, depression, ADHD, bipolar disorder, PTSD, and OCD. Specialized care is also available for children, adolescents, and individuals navigating pregnancy and postpartum mental health concerns. However, Talkiatry is transparent about its limitations and does not provide care for conditions that require intensive in-person intervention, such as eating disorders or schizophrenia. Virtual care offers key benefits that are central to Talkiatry's appeal. Patients can attend appointments from any private space, eliminating travel time and reducing the burden of scheduling. The flexibility of virtual sessions also makes psychiatric care more accessible to individuals in rural or underserved areas, where local mental health services are often limited or nonexistent. Affordability is another area where Talkiatry distinguishes itself. The company only works with patients whose insurance it accepts, thereby ensuring care remains in-network. Costs vary depending on the patient's insurance plan, but for many, fees are comparable to a standard copay. For outstanding balances over $250, Talkiatry offers structured payment plans with flexible timelines. Recent internal data from the practice underscores the clinical efficacy of its model. In a peer-reviewed study conducted by Talkiatry, 65% of patients with anxiety or depression reported no longer experiencing clinically significant symptoms after an average of five visits - an outcome that aligns with national benchmarks for high-quality outpatient psychiatric care*. The recognition by Better Business Advice reflects a growing shift in how mental health services are delivered and consumed. As patients increasingly turn to digital platforms for healthcare, Talkiatry exemplifies how virtual psychiatry can be both scalable and deeply personal. Talkiatry does not provide emergency or crisis services. Individuals in immediate distress are urged to contact emergency services or the Suicide and Crisis Lifeline by dialing 988. To read the full review, visit the Better Business Advice website. *65% of patients no longer reported clinically significant symptoms; Person C, O'Connor N, Koehler L, Venkatachalam K, Gaveras G; Evaluating Clinical Outcomes in Patients Being Treated Exclusively via Telepsychiatry: Retrospective Data Analysis; JMIR Form Res 2023;7:e53293; URL: DOI: 10.2196/53293. Outcomes data based on retrospective study of de-identified data from 1,826 Talkiatry patients who completed GAD7 or PHQ8 at their first visit and one subsequent visit. The first visit was between 2/1/23 and 5/26/23. 'Not clinically significant' defined as a GAD7/PHQ8 score less than 10." About TalkiatryTalkiatry is a national mental health practice that provides in-network psychiatry and therapy. They were co-founded by a patient and a triple-board-certified psychiatrist to solve the problems both groups face in accessing and providing the highest quality mental healthcare. 60% of adults in the U.S. with a diagnosable mental illness go untreated every year because care is inaccessible, while 45% of clinicians are out of network with insurers because reimbursement rates are low and paperwork is unduly burdensome. With innovative technology and a human-centered philosophy, Talkiatry provides patients with the care they need - and allows psychiatrists to focus on why they got into medicine. Learn more at and follow us on Instagram, TikTok, and LinkedIn. About Better Business Advice: Better Business Advice is a business advice website dedicated to helping businesses succeed. As an affiliate, Better Business Advice may earn commissions from services mentioned in the links provided. The information provided by Better Business Advice does not, and is not intended to, constitute legal advice; instead, all information, content, and materials are for general informational purposes only. CONTACT: Drew Thomas (press@
Associated Press
22-05-2025
- Health
- Associated Press
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy ® (semaglutide), which includes both the medication and access to LifeMD's virtual weight management program. As part of its collaboration with Novo Nordisk announced last month, LifeMD is offering Wegovy ® at a discounted price of $199 for eligible patients through its recently completed integration with NovoCare ® Pharmacy, with an additional $100 covering LifeMD's clinical care, onboarding, and ongoing support. The collaboration with Novo Nordisk strengthens LifeMD's ability to deliver branded GLP-1 medications through a fully integrated care experience, addressing the needs of the growing number of self-pay patients seeking FDA-approved replacements for compounded therapies. LifeMD's platform provides an end-to-end model—from virtual consultation to prescription fulfillment to ongoing coaching and support—ensuring continuity of care at every stage of the weight loss journey. The $299 bundle is available to eligible patients prescribed Wegovy ® on or before June 30, 2025. Beginning with the second month, the program will cost $599 per month, with no long-term commitment required. 'Our collaboration with Novo Nordisk reflects LifeMD's commitment to improving affordability, convenience, and access for patients seeking medically guided weight loss,' said Justin Schreiber, Chairman and CEO of LifeMD. 'This bundled solution provides a seamless, affordable on-ramp to FDA-approved GLP-1 therapy—replacing the fragmented and often inconsistent experience many patients have faced with compounded alternatives. We look forward to expanding this collaboration to reach more patients and drive better outcomes at scale.' 'Novo Nordisk continues to work with LifeMD to expand access to authentic, FDA-approved Wegovy ®, a proven therapy for chronic weight management along with a reduced calorie diet and increased physical activity,' said Dave Moore, Executive Vice President, US Operations of Novo Nordisk Inc. 'This collaboration enables patients to begin their treatment journey through a trusted virtual care platform. We look forward to this collaboration and improving access and outcomes for patients nationwide.' LifeMD's weight management program delivers personalized, clinically guided care for patients across the U.S. By leveraging its vertically integrated platform—including a 50-state medical group and national diagnostic lab partnerships—LifeMD offers a seamless experience from consultation through prescription fulfillment and ongoing support. To learn more about LifeMD's $299 introductory bundled offering with Wegovy®, please visit Wegovy® is the first GLP-1 therapy approved in the United States for both chronic weight management and cardiovascular risk reduction in adults with obesity. Through this offering, all doses of Wegovy® are available in an injector pen – by prescription – to eligible LifeMD patients who are uninsured or whose insurance does not cover prescription weight-loss medications. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit Cautionary Note Regarding Forward Looking Statements This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: 'believe,' 'expect,' 'anticipate,' 'project,' 'should,' 'plan,' 'will,' 'may,' 'intend,' 'estimate,' 'predict,' 'continue,' and 'potential,' or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition. Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, 'Risk Factors' identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods. Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation. Investor Contact: Marc Benathen, Chief Financial Officer [email protected] Media Contact: Jessica Friedeman, Chief Marketing Officer [email protected]
